Search results
PROMOTED
Start date:
Mar 18, 2026
Join leading international experts for an in-depth, case-based masterclass focused on transcatheter edge-to-edge repair (TEER) in secondary mitral regurgitation (MR). This webinar will explore how anatomical variations influence procedural planning, leaflet grasping strategies, and execution techniques, delivering practical insights you can apply directly to clinical practice.Chaired by Prof…
View more
Added:
1 month ago
Navigate real-world tricuspid valve intervention challenges with Dr Carla AgatielloThis presentation, part of Women As One's CLIMB® 2025 Skills Training Program on Structural Interventions, brings practical insights from the evolving landscape of tricuspid procedures in Latin America, where these innovative interventions represent the cutting edge of structural heart disease management.Dr…
View more
Added:
2 months ago
PCR London Valves 2025 - In this interview, Dr Jonathan Schwartz, leading structural interventional cardiologist at the Sanger Heart and Vascular Institute, Lake Forest University (Charlotte, NC, US) shares his insights into the evolving landscape of transcatheter tricuspid valve therapies.Dr Schwartz examines the latest real-world and clinical trial evidence for the EVOQUE and TriClip systems,…
View more
Start date:
Dec 03, 2025
Severe tricuspid regurgitation (TR) remains an under-recognised and under-treated condition, stressing the importance of timely identification and referral to improve clinical outcomes.In this interactive session, Prof Marianna Adamo (University of Brescia, Brescia, IT) and Prof Volker Rudolph (Heart and Diabetes Center NRW, Bad Oeynhausen, DE) moderate an expert faculty of Prof Marta Sitges …
View more
Start date:
Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday…
View more
Added:
7 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result…
View more
Added:
7 months ago
New York Valves 2025 - Echocardiographic outcomes from the TRISCEND II substudy reinforce the effectiveness of TTVR compared to medical therapy alone at one year post transcatheter tricuspid valve replacement (TTVR).Dr Paul Grayburn (Baylor Scott and White Research Institute, Dallas, US) joins us to discuss echocardiographic outcomes one year post TTVR from the TRISCEND II substudy which…
View more
Making the Right Referral
Video Series
Added:
8 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating…
View more
ICE and TEE Guidance for TriClip Tricuspid TEER
Video Series